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Abstract The dipeptidyl peptidase IV (DPPIV) gene encodes a
brush border membrane exopeptidase that is expressed in a
tissue-restricted fashion. To examine the regulation of DPPIV
transcription in various tissues in vivo, we examined the
expression of DPPIV 5P-flanking region (promoter)^human
growth hormone reporter constructs in transgenic mice. These
mice exhibited cell-type specific reporter expression in kidney.
Surprisingly, however, only very low to non-detectable levels of
reporter were found in small intestine. These results indicate that
DNA elements sufficient for DPPIV expression in kidney,
but not intestine, reside in the 5P-flanking region of the
gene. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) is expressed
in several tissues including small intestine, kidney, liver and
lung. This hydrolase is a brush border membrane-associated
amino terminus exopeptidase with high activity towards pep-
tides with proline in the pentultimate position. In the intes-
tine, this enzyme plays an important role in the digestion of
proline-containing dietary proteins [1,2]. In kidney, studies
using a rat strain lacking DPPIV indicate that the enzyme is
required for urinary protein digestion prior to resorption by
the proximal tubules [3]. In other tissues, the role of DPPIV is
less clear although several functions have been proposed in-
cluding lymphocyte activation, cell-basement membrane inter-
action, and modulation of hormonal activity [4^7].
Our laboratory has had a long-standing interest in brush
border peptidases, their substrate speci¢cities, and their regu-
lation at the transcriptional level. We have demonstrated that
a proline-rich diet induces DPPIV expression, mediated
through increases in transcription [8]. Moreover, we have iso-
lated the DPPIV gene 5P-£anking sequence, demonstrated that
it has promoter activity in cultured cells, and characterized
elements important for its activity in vitro [9,10]. A cognate
hepatic nuclear factor-1 (HNF-1) binding site located between
bases 3147 and 3135 appears to be especially important, as
point mutations in this site reduce promoter activity to 5^10%
of the non-mutated control [10]. We have also identi¢ed a
consensus E-box motif in the DPPIV 5P-£anking sequence
that binds upstream stimulatory factor, resulting in transcrip-
tional activation [11]. The factors necessary for e¡ecting tissue
and cell-type speci¢c expression of DPPIV transcription how-
ever, remain to be determined. Since DPPIV is expressed in
several di¡erent tissues, its expression may be dependent upon
di¡erent factors in di¡erent cell-types.
In order to examine tissue and cell-type speci¢c DPPIV
expression in vivo, we produced transgenic mice containing
DPPIV promoter^reporter constructs. Analysis of these mice
reveals appropriate transgene expression in the kidney, but a
lack of expression in the intestine. These results suggest that
the DPPIV 5P-£anking sequence contains elements su⁄cient
to drive cell-type speci¢c transcription in the kidney and fur-
ther indicate that additional cis-elements are required to e¡ect
DPPIV expression in the intestine.
2. Materials and methods
RNA was extracted from mouse tissue using Tri reagent (Molecular
Research Center, Cincinnati, OH, USA) as described [12]. Northern
blots were prepared using 10 Wg of total RNA per lane and hybridized
to DPPIV [8], human growth hormone (hGH) [12], or glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) [12] probes. hGH immunohis-
tochemistry was conducted using the silver-enhanced immunogold
technique as previously [12]; tissues were ¢xed in Bouin’s solution
and sections were counter-stained with hematoxylin.
Because the human DPPIV gene was found to utilize multiple tran-
scription start sites between bases 3115 and 351 it is customary to
number the promoter from the start of translation [9]. Human and
mouse DPPIV promoter^hGH reporter transgenes were constructed
using bases 3952 to 341 of the human DPPIV promoter [9] and bases
31711 to 313 of the mouse DPPIV promoter [13] in conjunction with
the hGH structural gene contained in the pOGH expression vector
[12]. For construction of the human DPPIV^hGH transgene, the poly-
merase chain reaction (PCR) was used with primers M13A (5P-
GCGCGTTGGCCGATTCATT) and DPP-7 (5PGAAGGATCC-
CAGGCAGAAG, introduced BamHI site underlined) to amplify
the appropriate fragment from the M13mp19 XbaI^XbaI clone used
for sequencing [9]. This fragment was digested with HindIII and Bam-
HI and cloned into the same sites of pOGH. The promoter^reporter
transgene containing the human DPPIV promoter cloned into the 5P-
untranslated region of the hGH structural gene was then retrieved
with HindIII and EcoRI for transgenic mouse production. For prep-
aration of the mouse DPPIV^hGH construct, C57Bl/6 mouse DNA
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was ampli¢ed by PCR using primers MD-1 (5P-GAGATATCGTC-
GACTAACTACCCAAATGAGTTCTC) and MD-2 (5P-TTCATGG-
TCGGGCGGATCCTTGAAACTGAACTC), introduced SalI and
BamHI sites underlined. Following digestion with SalI and BamHI,
the fragment was cloned into the same sites of pOGH; the mouse
DPPIV^hGH promoter construct was then retrieved with SalI/EcoRI
for transgenic mice production. The PCR fragments generated in
these procedures were sequenced to assure faithful ampli¢cation.
Fig. 1 illustrates the linkage between the promoter and reporter in
both constructs.
All transgenic mice used in this study were produced at the Uni-
versity of California at Irvine (UCI) Transgenic Mouse Facility except
for human strains 18 and 40, which were produced by the DNX
corporation, Princeton, NJ, USA. Mice from the UCI facility were
prepared using C57Bl/6UBALB/c F2 hybrid zygotes, mice from the
DNX corporation were prepared using C57BL/6USJL F2 hybrid zy-
gotes. Founder mice were mated with C57Bl/6 mice to propagate lines
and all mice used in these studies were from the founder to F2 gen-
erations. Transgene-bearing mice were detected using PstI-digested
tail DNA in blot analysis using the proximal 741 base PstI fragment
of the hGH structural gene as a probe.
3. Results
Past studies have con¢rmed the utility of hGH as a reporter
gene in transgenic mice [12,14^16]. Its expression is detectable
in whole tissues by Northern blot analysis and in histological
sections by immunohistochemistry. Thus, this reporter was
chosen for work with the DPPIV promoter^reporter con-
structs.
Five independent lines of human DPPIV^hGH promoter^
reporter transgenics were obtained. These lines all contained
1^5 copies of transgene in their genome and the transgenics
were similar to their normal litter mates in appearance and
behavior. Mice from each line were dissected, RNA was ex-
tracted from tissues, and Northern analysis was performed to
detect a hGH message (Fig. 2). In line 5, only very low or
undetectable amounts of hGH reporter message was detected
in any tissue, suggesting that the transgene became incorpo-
rated in a transcriptionally silenced region of the genome.
Also, as expected, the non-transgenic control failed to express
hGH message. The other four lines exhibited reporter expres-
sion in select tissues. High levels of hGH message were pro-
duced in the kidneys of lines 6, 18, and 40 and in the liver of
strains 3, 6 and 18. Inappropriate expression of reporter was
found in the colon of line 3 and the brain of line 6. Surpris-
ingly however, low or no reporter expression was observed in
the intestine of any line despite the fact that high levels of
endogenous DPPIV are expressed in this tissue [17]. Because
of this unexpected ¢nding the blots were hybridized again to a
GAPDH probe to ascertain that RNA was loaded in all lanes,
typical results demonstrating this are included in Fig. 2.
In order to determine the tissue expression levels of endog-
enous DPPIV mRNA in the transgenics, Northern blots were
prepared using RNA from two transgenic lines and hybridized
to a DPPIV probe (Fig. 3). Here we found that the highest
levels of DPPIV message were found in small intestinal RNA;
kidney and liver in contrast, expressed lower but signi¢cant
levels of message. Thus, these transgenic lines exhibited high
levels of DPPIV message in the intestine, similar to non-trans-
genic animals [17].
Other than the HNF-1 site implicated mechanistically in
DPPIV promoter activity [10], little conservation between
Fig. 1. Sequences of the human and mouse DPPIV promoter^hGH reporter constructs near the promoter^reporter transition sites. 5P-£anking
region sequence is indicated using lowercase letters with the start of transcription of the longest known transcripts indicated by the bent arrows.
DPPIV 5P-untranslated regions between the start of transcription and the BamHI sites (bold) are indicated by uppercase letters. The BamHI
sites demarcate the transitions between the 5P-untranslated regions of the DPPIV promoters and the 5P-untranslated region of the hGH reporter
genes. The ¢rst two codons are shown to mark the translation start sites of the reporters.
Fig. 2. Northern blot analysis of reporter expression in the human
DPPIV promoter^hGH reporter transgenic mice. The line and sex
of the animals are indicated on the left side of the ¢gure (N indi-
cates non-transgenic). RNA was extracted from the indicated tis-
sues. PSI, MSI, and DSI indicate samples of proximal, middle and
distal small intestine, respectively. Swatches of autoradiograms from
the various tissues are shown, the ¢rst six autoradiograms were
probed using the hGH reporter probe, the ¢nal autoradiogram is of
a GAPDH control indicating RNA loading in all lanes.
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the 5P-£anking regions of mouse and human DPPIV is evi-
dent. This contrasts with other intestinal genes such as mucin
MUC2 and sucrase^isomaltase in which at least the ¢rst 200
bases upstream of the start of transcription are well conserved
[18,19]. Because of the di¡erences present between the mouse
and the human sequences, we considered the possibility that
this lack of conservation was responsible for the absence of
transgene expression in the intestine. To test this, we prepared
a mouse DPPIV promoter^hGH reporter construct and pre-
pared transgenics using this. We used longer segments of pro-
moter (5P-£anking regions) and 5P-message untranslated re-
gions with this construct as we believed that this had the
best chance of containing elements necessary for intestinal
expression. Four transgenic founders were obtained contain-
ing the mouse DPPIV promoter^hGH reporter construct.
These mice, similar to the previous set, also all contained 1^
5 copies of the transgene. Fig. 4 shows expression of reporter
message in the tissues of this set of transgenics. These mice,
similar to their counterparts with the human DPPIV pro-
moter, expressed reporter message at high levels in their kid-
neys and livers. Also similar to the previous lines, these lines
failed to express reporter in their intestines. Inappropriate
reporter expression was not observed in colon or brain
when the mouse 5P-£anking sequence was used. Moreover,
careful comparison of Figs. 2 and 4 indicates no expression
of reporter in the intestines when the mouse promoter was
used while trace amounts appeared in some lines containing
the human promoter^reporter construct.
DPPIV has been localized to the brush border membrane of
the proximal tubules of the kidney nephron where it appar-
ently functions in protein degradation prior to resorption
[3,17]. Thus, in evaluating the speci¢city of reporter expres-
sion in the kidney, it is important to determine which cells
express the reporter. We utilized mouse DPPIV^hGH line 2
for this purpose as it exhibits the highest level of reporter
expression and is therefore most amenable to immunohisto-
chemical analysis. We determined using this technique that
reporter expression is localized to a select group of tubules
in the kidney, in fact the proximal tubules (Fig. 5). These cells
are distinguishable from the cells of the distal tubules which
lack a brush border membrane and have smaller cell bodies.
Cells of the distal tubules, in contrast, can be seen to lack
reporter expression (Fig. 5). Also shown in Fig. 5 are results
using a non-transgenic mouse kidney, in which immunostain-
ing is absent. Thus, hGH reporter is expressed in a cell-type
speci¢c manner in the kidney of these mice.
4. Discussion
Our results indicate that the DNA elements required for
expression of DPPIV in the kidney are located on the prox-
imal portion of the 5P-£anking region of the DPPIV structural
gene. Eight transcriptionally active mouse lines were produced
using both human and mouse DPPIV promoter^hGH report-
er transgenes and all of these lines expressed detectable re-
porter (hGH) message in their kidneys (Figs. 2 and 4). This
expressed transgene product was found to be appropriately
localized in cells of the proximal tubules of the nephron in
mouse line 2, thus demonstrating that transgene expression in
the kidney is cell type-speci¢c as well. Surprisingly however,
none of the lines expressed reporter in their intestine despite
the fact that the highest level of endogenous DPPIV expres-
sion occurs in this tissue. This indicates that additional DNA
binding elements are required for DPPIV expression in the
intestine. The elements appear to located elsewhere than be-
tween bases 31711 and 313 of the mouse promoter, the lon-
gest construct used. Furthermore, it can be inferred from this
data that a di¡erent set of DNA binding proteins (transcrip-
tion factors) are used to achieve DPPIV expression in the
kidney and intestine rather than altered levels of the same
factors, as the factors required for transcription apparently
bind to di¡erent elements in the two di¡erent tissues. Thus,
while DPPIV is expressed in several cell types, its expression
appears to utilize a relatively speci¢c set of factors in the
various cell types in which it is expressed.
Transgene expression in the liver generally paralleled ex-
pression in the kidney in the various lines, however there
were some exceptions to this. Human line 40 and mouse
line 2 expressed reporter at higher levels in the kidney while
human line 3 expressed higher in the liver (Figs. 2 and 4). This
phenomenon could be related to the site of integration of the
transgene. For example, if integration occurred near an ele-
ment that causes activation of gene expression in the liver then
transgene expression in this tissue would be elevated. The
same phenomenon is also likely to be responsible for trans-
Fig. 3. Northern blot analysis of endogenous DPPIV message ex-
pression in human DPPIV promoter lines 18 and 40. Annotation is
as in Fig. 2.
Fig. 4. Northern blot analysis of reporter expression in the mouse
DPPIV promoter^hGH reporter transgenic mice. Annotation is as
in Fig. 2.
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gene expression in the colon in human line 3 and the brain in
human line 6. It is also noteworthy that transcription seemed
to be more tightly controlled when constructs containing the
mouse promoter were used than when using constructs con-
taining the human promoter; i.e. only transcription in the
liver and kidney was observed. This is perhaps due to poor
conservation between the human and mouse promoter se-
quences, causing incomplete suppression in inappropriate tis-
sues with the human promoter. An alternative explanation is
that longer regions of 5P-£anking sequence and 5P-untrans-
lated message sequence were used to prepare the mouse pro-
moter construct than were used in the human promoter con-
struct.
The data presented in this paper indicate that DNA ele-
ments required for DPPIV gene transcription in the intestine
are located elsewhere than in the proximal 5P-£anking region
of the gene. This di¡ers from results obtained to date with
several other genes that are expressed in intestinal absorptive
cells. Similar experiments using transgenic mice have demon-
strated that elements required for tissue speci¢c expression in
the intestine are found on the 5P-£anking regions of the su-
crase^isomaltase gene and fatty acid binding protein genes
[14^16]. Our work with an intestinal goblet cell speci¢c gene
(MUC2) indicates that elements necessary for cell type speci¢c
expression in the small intestine, but not the colon, reside on
the 5P-£anking region [12]. Thus, the regulation of DPPIV is
dissimilar in this regard from other intestine-speci¢c genes
that have been studied in this detail in vivo. It is worth noting
that the second intron of the DPPIV gene is approximately 20
kb and genes are known where regulatory sequences are lo-
cated in introns or even in the 3P-£anking region [20^22].
Moreover, sequences located many kb from the start of tran-
scription have been shown to be important in tissue-speci¢c
gene regulation [23,24]. The elements that control DPPIV
gene expression in the intestine could be located in any of
these locations.
Comparison of the mouse and human DPPIV 5P-£anking
sequences indicates an absolute conservation of the HNF-1
element [10]. This occurs despite a lack of conservation else-
where in the proximal 5P-£anking sequence. HNF-1 transcrip-
tion factors (HNF-1K and HNF-1L) are expressed in multiple
tissues including intestine, liver, and kidney [25,26] and are
therefore present in most if not all of the tissues that express
DPPIV [17]. Previous work in our laboratory has demon-
strated that mutations in this site diminish DPPIV promoter
activity to 5^10% of unmutated controls [10]. Moreover, in-
creases in HNF-1K are correlated with increases in DPPIV
levels during di¡erentiation in Caco-2 cells [27]. Thus, the
HNF-1 site appears to be very important for DPPIV pro-
moter function even though it may not be the sole determi-
nant of cell-type speci¢city of the promoter.
In summary, we have demonstrated using promoter^report-
er constructs in transgenic mice that elements required for cell
type-speci¢c expression of DPPIV in the kidney are located on
the 5P-£anking region and that a di¡erent set of elements are
utilized in the intestine. These results indicate therefore, that
the DPPIV promoter utilizes multiple sets of DNA binding
elements and transcription factors for expression in various
tissues. Additional studies will be required to determine the
unique combinations of transcription factors and DNA bind-
ing elements required for DPPIV gene expression in each of
the individual tissues.
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Fig. 5. Immunohistochemical analysis of hGH reporter expression in mouse DPPIV^hGH line 2 kidney. A and B are di¡erent magni¢cations
of a transgenic kidney and C and D are from a non-transgenic litter mate. The arrows indicate proximal tubules (identi¢ed by their abundant
cytoplasm and brush border membrane), the arrowheads indicate distal tubules. The bars are 100 Wm.
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